Abstract
ObjectivesWe examined the return to fertility and transgenerational impact of treatment with WIN 18,446, an experimental male contraceptive, in mice. Study designWe paired male mice treated with WIN 18,446 for 4 weeks to suppress spermatogenesis, followed by a 9-week recovery, and mated them with normal females to assess fertility. F1 generation mice were subsequently mated to ascertain any transgenerational impact of treatment on fertility. Testes were examined histologically. ResultsWIN 18,446–treated mice and their progeny produced normally sized litters (6.5 pups per litter after treatment and 7.3 pups per litter from the progeny). However, testes histology revealed rare residual intratesticular foci of mineralization after treatment. ConclusionsFertility normalizes after WIN 18,446 treatment, and progeny also have normal fertility.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
